Craig Hallum initiated coverage on Forma Therapeutics with a new price target
$FMTX
Biotechnology: Pharmaceutical Preparations
Health Care
Craig Hallum initiated coverage of Forma Therapeutics with a rating of Buy and set a new price target of $58.00